本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aclaris Therapeutics

1.28
-0.1600-11.11%
盘后1.27-0.0100-0.78%19:18 EDT
成交量:38.40万
成交额:51.18万
市值:1.39亿
市盈率:-0.75
高:1.45
开:1.44
低:1.28
收:1.44
数据加载中...
2020/03/13

重要事件披露

Current report, items 1.01 and 9.01
2020/03/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/06

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/25

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/08

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/19

超过5%披露

[Amend] General statement of acquisition of beneficial ownership